← Back to Analyst Consensus 
ESLA Buy
Estrella Immunopharma, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Feb 9, 2026 | D. Boral Capital | maintain | Buy → Buy | $8 | 34% |
| Jan 28, 2026 | D. Boral Capital | maintain | Buy → Buy | $8 | 34% |
| Nov 3, 2025 | D. Boral Capital | maintain | Buy → Buy | $16 | 34% |
| Aug 12, 2025 | D. Boral Capital | maintain | Buy → Buy | $16 | 34% |
| Jun 3, 2025 | D. Boral Capital | maintain | Buy → Buy | $16 | 34% |
| May 29, 2025 | D. Boral Capital | maintain | Buy → Buy | $16 | 34% |
| Feb 21, 2025 | D. Boral Capital | maintain | Buy → Buy | $16 | 34% |
| Feb 18, 2025 | D. Boral Capital | initiate | — → Buy | $16 | 34% |
Price Target Trend
Apr 25, 2026 Latest: $12 Oct 23, 2026
EPS Estimates
+1q $-0.07
Lo: $-0.07 Hi: $-0.07
1 analysts ▲1
0y $-0.29
Lo: $-0.29 Hi: $-0.29
1 analysts ▲1
0q $-0.08
Lo: $-0.08 Hi: $-0.08
1 analysts ▲1
+1y $-0.32
Lo: $-0.32 Hi: $-0.32
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days